Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 2.04% is 133% above its 5-year average of -6.26%, around the middle of its 5-year range (-14.72%–11.68%).
As of the fiscal period ended Tuesday, June 30, 2026. 167.73% above its 12-month average of -3.02%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 2.04%.
RETURN ON EQUITY (ROE)
2.04%
RETURN ON EQUITY (ROE) AVG TTM
-3.02%
RETURN ON EQUITY (ROE) AVG 3Y
-6.53%
RETURN ON EQUITY (ROE) AVG 5Y
-6.26%
RETURN ON EQUITY (ROE) AVG 10Y
-11.28%
RETURN ON EQUITY (ROE) AVG 15Y
-13.14%
RETURN ON EQUITY (ROE) AVG 20Y
-18.41%
CURRENT VS TTM AVG
+167.73%
CURRENT VS 3Y AVG
+131.28%
CURRENT VS 5Y AVG
+132.64%
CURRENT VS 10Y AVG
+118.11%
CURRENT VS 15Y AVG
+115.55%
CURRENT VS 20Y AVG
+111.10%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+104.86%
vs the sector median at left
AtriCure, Inc.
Market Cap
$2.77B
Return on Equity (ROE)
2.04%
TTM Avg
-3.02%
3Y Avg
-6.53%
5Y Avg
-6.26%
Market Cap
$2.79B
Return on Equity (ROE)
29.28%
TTM Avg
27.86%
3Y Avg
4.54%
5Y Avg
-12.45%
Market Cap
$2.73B
Return on Equity (ROE)
-361.91%
TTM Avg
-763.19%
3Y Avg
-396.22%
5Y Avg
-320.76%
Market Cap
$2.86B
Return on Equity (ROE)
-73.97%
TTM Avg
-48.15%
3Y Avg
-105.34%
5Y Avg
-79.84%
Market Cap
$2.68B
Return on Equity (ROE)
-56.91%
TTM Avg
-24.13%
3Y Avg
-9.83%
5Y Avg
-11.19%
Market Cap
$2.66B
Return on Equity (ROE)
95.64%
TTM Avg
115.72%
3Y Avg
76.74%
5Y Avg
3213.80%
Market Cap
$2.65B
Return on Equity (ROE)
-25.47%
TTM Avg
-23.80%
3Y Avg
14.67%
5Y Avg
14.67%
Market Cap
$2.63B
Return on Equity (ROE)
-0.38%
TTM Avg
-26.55%
3Y Avg
-13.53%
5Y Avg
-6.91%
Market Cap
$2.61B
Return on Equity (ROE)
-8.00%
TTM Avg
-28.91%
3Y Avg
-27.68%
5Y Avg
-39.13%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AtriCure, Inc. (ATRC) | $2.77B | 2.04% | -3.02% | -6.53% | -6.26% |
| TransMedics Group, Inc. (TMDX)vs › | $2.79B | 29.28% | 27.86% | 4.54% | -12.45% |
| Precigen, Inc. (PGEN)vs › | $2.73B | -361.91% | -763.19% | -396.22% | -320.76% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.86B | -73.97% | -48.15% | -105.34% | -79.84% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | -56.91% | -24.13% | -9.83% | -11.19% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.66B | 95.64% | 115.72% | 76.74% | 3213.80% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.65B | -25.47% | -23.80% | 14.67% | 14.67% |
| Neogen Corporation (NEOG)vs › | $2.63B | -0.38% | -26.55% | -13.53% | -6.91% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.61B | -8.00% | -28.91% | -27.68% | -39.13% |
| Privia Health Group, Inc. (PRVA)vs › | $2.58B | 0.00% | 2.68% | 1.94% | -2.51% |
ROE
2.0%
ROA
1.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 2.04% |
| 2026-03-31 | -0.93% |
| 2025-12-31 | -2.33% |
| 2025-09-30 | -6.04% |
| 2025-06-30 | -7.83% |
| 2025-03-31 | -8.40% |
| 2024-12-31 | -9.70% |
| 2024-09-30 | -8.37% |
| 2024-06-30 | -8.68% |
| 2024-03-31 | -8.16% |
| 2023-12-31 | -6.53% |
| 2023-09-30 | -5.36% |
| 2023-06-30 | -6.06% |
| 2023-03-31 | -8.30% |
| 2022-12-31 | -10.17% |
| 2022-09-30 | -12.44% |
| 2022-06-30 | 11.68% |
| 2022-03-31 | 11.22% |
| 2021-12-31 | 10.38% |
| 2021-09-30 | 9.29% |
| 2021-06-30 | -14.72% |
| 2021-03-31 | -12.44% |
| 2020-12-31 | -11.68% |
| 2020-09-30 | -10.94% |
| 2020-06-30 | -12.02% |
| 2020-03-31 | -20.22% |
| 2019-12-31 | -14.23% |
| 2019-09-30 | -8.72% |
| 2019-06-30 | -8.45% |
| 2019-03-31 | -6.95% |
| 2018-12-31 | -8.48% |
| 2018-09-30 | -12.39% |
| 2018-06-30 | -12.71% |
| 2018-03-31 | -17.53% |
| 2017-12-31 | -16.69% |
| 2017-09-30 | -20.73% |
| 2017-06-30 | -20.11% |
| 2017-03-31 | -21.01% |
| 2016-12-31 | -19.79% |
| 2016-09-30 | -20.54% |
| 2016-06-30 | -19.77% |
| 2016-03-31 | -17.49% |
| 2015-12-31 | -14.58% |
| 2015-09-30 | -17.25% |
| 2015-06-30 | -12.41% |
| 2015-03-31 | -10.71% |
| 2014-12-31 | -12.23% |
| 2014-09-30 | -11.74% |
| 2014-06-30 | -13.51% |
| 2014-03-31 | -12.83% |
| 2013-12-31 | -15.79% |
| 2013-09-30 | -23.46% |
| 2013-06-30 | -21.82% |
| 2013-03-31 | -20.35% |
| 2012-12-31 | -60.26% |
| 2012-09-30 | -55.99% |
| 2012-06-30 | -41.39% |
| 2012-03-31 | -39.60% |
| 2011-12-31 | -34.94% |
| 2011-09-30 | -20.91% |
| 2011-06-30 | -19.13% |
| 2011-03-31 | -19.05% |
| 2010-12-31 | -22.66% |
| 2010-09-30 | -39.42% |
| 2010-06-30 | -62.65% |
| 2010-03-31 | -66.60% |
| 2009-12-31 | -96.52% |
| 2009-09-30 | -94.60% |
| 2009-06-30 | -65.01% |
| 2009-03-31 | -65.49% |
| 2008-12-31 | -34.92% |
| 2008-09-30 | -27.35% |
| 2008-06-30 | -28.84% |
| 2008-03-31 | -31.61% |
| 2007-12-31 | -31.05% |
| 2007-09-30 | -36.98% |
| 2007-06-30 | -36.51% |
| 2007-03-31 | -55.07% |
| 2006-12-31 | -44.69% |
| 2006-09-30 | -39.08% |
| 2006-06-30 | -38.23% |
| 2006-03-31 | -33.29% |
| 2005-12-31 | -29.37% |
| 2005-09-30 | -32.11% |
